Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Recap: Candel Therapeutics Q3 Earnings

Candel Therapeutics (NASDAQ:CADL) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Candel Therapeutics (NASDAQ:CADL) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Candel Therapeutics missed estimated earnings by 52.63%, reporting an EPS of $-0.29 versus an estimate of $-0.19.

Revenue was down $31 thousand from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.03 which was followed by a 8.49% increase in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Candel Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Nasdaq Tumbles 150 Points; US Private Sector Adds 107,000 Jobs In January

By Avi Kapoor
January 31, 10:41 AM
U.S. stocks traded mixed this morning, with the Nasdaq Composite falling around 150 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.13% to 38,517.77 while the NASDAQ fell 1.07% to 15,344.69. The S&P 500 also fell, dropping, 0.47% to 4,901.66.

CNXA